BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28033156)

  • 1. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma.
    Ansai SI; Anan T; Fukumoto T; Saeki H
    Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blaschkoid distribution of composite syringocystadenoma papilliferum and tubular apocrine adenoma without naevus sebaceous.
    Khullar G; Sharma S; Ramesh V; Mann KK
    Clin Exp Dermatol; 2019 Jun; 44(4):438-440. PubMed ID: 30251370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
    Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
    Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Syringocystadenoma Papilliferum with Tubular Papillary Adenoma of the Chest.
    Ito K; Ansai SI; Saeki H
    J Nippon Med Sch; 2017; 84(2):79-82. PubMed ID: 28502963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
    Tellechea O; Reis JP; Marques C; Baptista AP
    Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is tubular apocrine adenoma a distinct clinical entity?
    Ishiko A; Shimizu H; Inamoto N; Nakmura K
    Am J Dermatopathol; 1993 Oct; 15(5):482-7. PubMed ID: 8238787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex sweat gland hamartoma: A case report.
    Skopec Z; Berrebi KG; Stone M; Liu V
    J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringocystadenoma papilliferum arising in a naevus sebaceous.
    Faheem NAA; Kwan Z; Yong ASW; Ch'ng CC; Tan KK; Naicker M; Tan LL
    Malays J Pathol; 2019 Apr; 41(1):47-49. PubMed ID: 31025637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologists.
    Kazakov DV; Bisceglia M; Calonje E; Hantschke M; Kutzner H; Mentzel T; Michal M; Mukensnabl P; Spagnolo DV; Rütten A; Rose C; Urso C; Vazmitel M; Zelger B
    Am J Dermatopathol; 2007 Jun; 29(3):256-63. PubMed ID: 17519623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
    Schewach-Millet M; Trau H
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tubulo-papillary apocrine adenoma in association with syringocystadenoma papilliferum].
    Ayadi L; Mallouli M; Kallel R; Charfi S; Makni S; Boudawara TS; Gouiaa N
    Ann Pathol; 2016 Oct; 36(5):355-357. PubMed ID: 27693311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocrine Papillary Hidrocystoma With Mucinous Metaplasia (Goblet Cell Type): A Case Report and Review of the Literature.
    Epperson J; Bergfeld W
    Am J Dermatopathol; 2023 May; 45(5):330-332. PubMed ID: 36939135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
    Blind A; Weingertner N; Cribier B
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenoma papilliferum of the scalp.
    Perlman KL; Kentosh JB
    Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenoma papilliferum on the mons pubis.
    Suzuki S; Al-Hajjaj S; Lee M; Bhawan J
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermoscopy of syringocystadenoma papilliferum.
    Lombardi M; Piana S; Longo C; Borsari S; Persechino F; Argenziano G; Moscarella E
    Australas J Dermatol; 2018 Feb; 59(1):e59-e61. PubMed ID: 28695704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.